Literature DB >> 17512005

The structure of human thioredoxin reductase 1 provides insights into C-terminal rearrangements during catalysis.

Karin Fritz-Wolf1, Sabine Urig, Katja Becker.   

Abstract

Human thioredoxin reductase (hTrxR) is a homodimeric flavoprotein crucially involved in the regulation of cellular redox reactions, growth and differentiation. The enzyme contains a selenocysteine residue at its C-terminal active site that is essential for catalysis. This redox center is located on a flexible arm, solvent-exposed and reactive towards electrophilic inhibitors, thus representing a target for antitumor drug development. During catalysis reducing equivalents are transferred from the cofactor NADPH to FAD, then to the N-terminal active site cysteine residues and from there to the flexible C-terminal part of the other subunit to be finally delivered to a variety of second substrates at the molecule's surface. Here we report the first crystal structure of hTrxR1 (Sec-->Cys) in complex with FAD and NADP(+) at a resolution of 2.8 A. From the crystals three different conformations of the carboxy-terminal arm could be deduced. The predicted movement of the arm is facilitated by the concerted action of the three side-chain residues of N418, N419 and W407, which act as a guiding bar for the C-terminal sliding process. As supported by previous kinetic data, the three visualized conformations might reflect different stages in enzymatic catalysis. Comparison with other disulfide reductases including human glutathione reductase revealed specific inhibitor binding sites in the intersubunit cavity of hTrxR that can be exploited for structure-based inhibitor development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17512005     DOI: 10.1016/j.jmb.2007.04.044

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  17 in total

1.  Selective targeting of selenocysteine in thioredoxin reductase by the half mustard 2-chloroethyl ethyl sulfide in lung epithelial cells.

Authors:  Yi-Hua Jan; Diane E Heck; Joshua P Gray; Haiyan Zheng; Robert P Casillas; Debra L Laskin; Jeffrey D Laskin
Journal:  Chem Res Toxicol       Date:  2010-06-21       Impact factor: 3.739

2.  Crystal structure of the human thioredoxin reductase-thioredoxin complex.

Authors:  Karin Fritz-Wolf; Sebastian Kehr; Michaela Stumpf; Stefan Rahlfs; Katja Becker
Journal:  Nat Commun       Date:  2011-07-12       Impact factor: 14.919

3.  Characterization of Lead Compounds Targeting the Selenoprotein Thioredoxin Glutathione Reductase for Treatment of Schistosomiasis.

Authors:  Haining Lyu; Pavel A Petukhov; Paul R Banta; Ajit Jadhav; Wendy A Lea; Qing Cheng; Elias S J Arnér; Anton Simeonov; Gregory R J Thatcher; Francesco Angelucci; David L Williams
Journal:  ACS Infect Dis       Date:  2020-01-24       Impact factor: 5.084

4.  Mapping the catalytic cycle of Schistosoma mansoni thioredoxin glutathione reductase by X-ray crystallography.

Authors:  Francesco Angelucci; Daniela Dimastrogiovanni; Giovanna Boumis; Maurizio Brunori; Adriana E Miele; Fulvio Saccoccia; Andrea Bellelli
Journal:  J Biol Chem       Date:  2010-07-21       Impact factor: 5.157

5.  The Enzymatic and Structural Basis for Inhibition of Echinococcus granulosus Thioredoxin Glutathione Reductase by Gold(I).

Authors:  Gustavo Salinas; Wei Gao; Yang Wang; Mariana Bonilla; Long Yu; Andrey Novikov; Veridiana G Virginio; Henrique B Ferreira; Marisol Vieites; Vadim N Gladyshev; Dinorah Gambino; Shaodong Dai
Journal:  Antioxid Redox Signal       Date:  2017-06-26       Impact factor: 8.401

6.  Identification of Michael acceptor-centric pharmacophores with substituents that yield strong thioredoxin reductase inhibitory character correlated to antiproliferative activity.

Authors:  Fei-Fei Gan; Kamila K Kaminska; Hong Yang; Chin-Yee Liew; Pay-Chin Leow; Choon-Leng So; Lan N L Tu; Amrita Roy; Chun-Wei Yap; Tse-Siang Kang; Wai-Keung Chui; Eng-Hui Chew
Journal:  Antioxid Redox Signal       Date:  2013-02-28       Impact factor: 8.401

7.  Effects of Mammalian Thioredoxin Reductase Inhibitors.

Authors:  Elias S J Arnér
Journal:  Handb Exp Pharmacol       Date:  2021

Review 8.  TrxR1 as a potent regulator of the Nrf2-Keap1 response system.

Authors:  Marcus Cebula; Edward E Schmidt; Elias S J Arnér
Journal:  Antioxid Redox Signal       Date:  2015-06-24       Impact factor: 8.401

9.  Thioredoxin Cross-Linking by Nitrogen Mustard in Lung Epithelial Cells: Formation of Multimeric Thioredoxin/Thioredoxin Reductase Complexes and Inhibition of Disulfide Reduction.

Authors:  Yi-Hua Jan; Diane E Heck; Robert P Casillas; Debra L Laskin; Jeffrey D Laskin
Journal:  Chem Res Toxicol       Date:  2015-10-19       Impact factor: 3.739

10.  Novel antitumor adamantane-azole gold(I) complexes as potential inhibitors of thioredoxin reductase.

Authors:  Adriana Garcia; Rafael Carvalhaes Machado; Richard Michael Grazul; Miriam Teresa Paz Lopes; Charlane Cimini Corrêa; Hélio F Dos Santos; Mauro Vieira de Almeida; Heveline Silva
Journal:  J Biol Inorg Chem       Date:  2016-02-03       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.